AVTX Avalo Therapeutics, Inc.
Fundamentals / CIK 0001534120 / USDAvalo Therapeutics, Inc. reported $59K in revenue and a net loss of $88.65M for the fiscal year ended December 31, 2025 (down 86.6% year over year), with a -161961.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AVTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$59K -86.6% YoY
-
Operating Income FY 2025-$95.56M -161961.0% margin
-
Net Income FY 2025-$88.65M -150259.3% net margin
-
Diluted EPS FY 2025-$1.61 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$393.0M Total debt: $153K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59K | $441K | $1.92M | $18.05M | $5.40M | $6.70M | $6.75M | $7.03M | $27.81M | $1.15M |
| Cost of Revenue | -- | -- | $1.28M | $3.43M | $1.49M | $300K | -$567K | $3.26M | $636K | $0 |
| Gross Profit | -- | -- | $640K | $14.62M | $3.91M | $6.40M | $7.32M | $3.77M | $27.18M | $1.15M |
| Research & Development | $50.08M | $24.44M | $13.78M | $31.31M | $59.84M | $32.19M | $11.76M | $5.79M | $4.37M | $10.15M |
| Selling, General & Admin | -- | -- | $10.30M | $20.71M | $27.48M | $19.76M | $11.61M | $11.06M | $8.51M | $7.08M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | $57.64M | $13.92M | $17.23M |
| Operating Income | -$72.92M | -$68.51M | -$27.35M | -$37.44M | -$82.13M | -$72.84M | -$16.14M | -$35.38M | $13.89M | -$16.08M |
| EBITDA | -$72.58M | -$68.34M | -$27.19M | -$37.27M | -$80.48M | -$71.00M | -$12.25M | -$30.82M | $14.32M | -$16.05M |
| Income Before Tax | -$78.09M | -$35.02M | -$31.53M | -$41.63M | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $165K | $114K | $14K | $28K | -$196K | -$2.79M | $280K | -$49K | $1.97M | $0 |
| Net Income | -$78.26M | -$35.13M | -$31.54M | -$41.66M | -$84.38M | -$63.50M | -$16.07M | -$40.05M | $11.87M | -$16.47M |
| Basic EPS | -$5.84 | -$7.94 | -$113.58 | -$1,063.00 | -- | -- | -- | -$3,429.94 | $1,200.48 | -$5,345.00 |
| Diluted EPS | -$5.84 | -$20.91 | -$113.58 | -$1,063.00 | -- | -- | -- | -$3,429.94 | $1,200.48 | -$5,345.00 |
| Basic Shares Outstanding | 13.4M | 4.4M | 277.7K | 39.2K | -- | -- | -- | 12.2K | 6.4K | 3.1K |
| Diluted Shares Outstanding | 13.4M | 7.5M | 277.7K | 39.2K | -- | -- | -- | 12.2K | 6.6K | 3.1K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $0 | -- | -- | $192K |
| Cost of Revenue | -- | -- | -- | -- | -- | $0 | -- | -- |
| Research & Development | $15.05M | $23.42M | $14.05M | $13.27M | $13.62M | $14.07M | $9.12M | $8.18M |
| Operating Income | -$23.40M | -$31.52M | -$20.90M | -$19.74M | -$19.20M | -$19.32M | -$14.67M | -$13.31M |
| EBITDA | -$23.38M | -$31.50M | -$20.88M | -$19.73M | -$19.14M | -$19.18M | -$14.53M | -$13.24M |
| Income Before Tax | -$18.94M | -$36.34M | -$19.62M | -$13.59M | -$30.61M | -$20.75M | -$13.14M | -$35.23M |
| Income Tax Expense | $7.0K | $18K | $12K | $130K | $11K | $16K | $8.0K | $114K |
| Net Income | -$18.95M | -$36.36M | -$19.63M | -$13.72M | -$30.62M | -$20.77M | -$13.15M | -$35.34M |
| Basic EPS | -$0.34 | -$0.83 | -$0.98 | -- | -$2.19 | -$1.92 | -$1.25 | -- |
| Diluted EPS | -$0.34 | -$0.83 | -$0.98 | -- | -$2.19 | -$1.92 | -$1.25 | -- |
| Basic Shares Outstanding | 55.1M | 43.6M | 20.1M | -- | 14.0M | 10.8M | 10.5M | -- |
| Diluted Shares Outstanding | 55.1M | 43.6M | 20.1M | -- | 14.0M | 10.8M | 10.5M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $15.86M | $134.5M | $7.42M | $13.17M | $54.59M | $18.92M | $3.61M | $10.65M | $2.47M | $5.13M |
| Short-Term Investments | $82.48M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Cash & Short-Term Investments | $98.30M | $134.5M | $7.42M | $13.17M | $54.59M | $18.92M | $3.61M | $10.65M | $2.47M | $5.13M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $1.06M | $2.18M | $1.00M | $822K | $2.94M | $132K |
| Inventory | -- | -- | $0 | $20K | $38K | $3.0K | $21K | $318K | $382K | $0 |
| Total Current Assets | $105.3M | $138.9M | $8.39M | $16.42M | $61.84M | $26.00M | $17.72M | $21.93M | $10.67M | $5.66M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $1.45M | $587K | $45K | $43K |
| Goodwill | $10.50M | $10.50M | $10.50M | $14.41M | $14.41M | $14.41M | $14.41M | $14.41M | $12.29M | $0 |
| Intangible Assets | -- | -- | -- | $0 | $38K | $1.58M | $2.43M | $3.77M | $17.66M | $0 |
| Long-Term Investments | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $11.17M | $11.84M | $12.60M | $16.95M | $18.37M | $17.75M | $18.38M | $48.32M | $32.13M | $106K |
| Total Assets | $116.5M | $150.7M | $20.99M | $33.37M | $80.21M | $43.76M | $36.11M | $70.25M | $42.81M | $5.77M |
| Accounts Payable | $137K | $283K | $446K | $2.88M | $3.37M | $2.57M | $2.08M | $1.45M | $1.30M | $1.01M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $1.05M | $0 | $2.35M |
| Deferred Revenue (Current) | -- | -- | $0 | $88K | $0 | -- | -- | -- | $0 | -- |
| Total Current Liabilities | $12.94M | $6.96M | $4.62M | $22.11M | $19.89M | $15.22M | $12.16M | $26.22M | $11.09M | $4.31M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $14.33M | $0 | $0 |
| Other Non-Current Liabilities | $35K | $350K | $1.37M | $1.71M | $2.30M | $1.88M | $1.11M | $386K | $24K | $0 |
| Total Non-Current Liabilities | $20.47M | $10.74M | $9.07M | $22.17M | $37.24M | $3.97M | $2.95M | $23.13M | $3.86M | $1.25M |
| Total Liabilities | $33.41M | $17.70M | $13.69M | $44.28M | $57.13M | $19.19M | $15.11M | $49.34M | $14.95M | $5.56M |
| Total Debt (incl. Leases) | $427K | $918K | $1.90M | $2.24M | $2.50M | $1.46M | $1.27M | $15.38M | $0 | $2.35M |
| Common Stock | $18K | $10K | $1.0K | $0 | $9.0K | $75K | $44K | $41K | $31K | $9.4K |
| Retained Earnings | -$448.5M | -$370.3M | -$335.1M | -$303.8M | -$262.2M | -$177.8M | -$114.3M | -$98.22M | -$58.17M | -$70.04M |
| Accumulated Other Comp. Income | $68K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | $83.05M | $133.0M | $7.30M | -$10.91M | $23.08M | $24.56M | $21.00M | $20.91M | $27.86M | $207K |
| Total Equity | $83.05M | $133.0M | $7.30M | -$10.91M | $23.08M | $24.56M | $21.00M | $20.91M | $27.86M | $207K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $64.99M | $85.38M | $24.99M | $15.86M | $26.96M | $42.29M | $125.0M | $134.5M |
| Short-Term Investments | $328.0M | $314.9M | $57.01M | $82.48M | $84.65M | $70.97M | -- | $0 |
| Cash & Short-Term Investments | $462.8M | $472.2M | $82.00M | $98.30M | $111.6M | $113.3M | $125.0M | $134.5M |
| Total Current Assets | $400.7M | $407.9M | $88.83M | $105.3M | $113.8M | $115.2M | $126.9M | $138.9M |
| Goodwill | $10.50M | $10.50M | $10.50M | $10.50M | $10.50M | $10.50M | $10.50M | $10.50M |
| Long-Term Investments | $69.81M | $71.88M | -- | $0 | -- | -- | -- | -- |
| Total Non-Current Assets | $80.69M | $82.85M | $11.06M | $11.17M | $11.25M | $11.40M | $11.58M | $11.84M |
| Total Assets | $481.4M | $490.8M | $99.89M | $116.5M | $125.1M | $126.6M | $138.5M | $150.7M |
| Accounts Payable | $2.46M | $3.35M | $356K | $137K | $474K | $2.37M | $681K | $283K |
| Total Current Liabilities | $24.09M | $21.13M | $11.60M | $12.94M | $7.97M | $9.26M | $5.62M | $6.96M |
| Other Non-Current Liabilities | $0 | $0 | $0 | $35K | $117K | $197K | $275K | $350K |
| Total Non-Current Liabilities | $20.79M | $20.99M | $19.97M | $20.47M | $25.58M | $12.75M | $10.29M | $10.74M |
| Total Liabilities | $44.88M | $42.12M | $31.57M | $33.41M | $33.55M | $22.01M | $15.91M | $17.70M |
| Total Debt (incl. Leases) | $153K | $242K | $328K | $427K | $555K | $679K | $801K | $918K |
| Common Stock | $54K | $53K | $25K | $18K | $18K | $11K | $11K | $10K |
| Retained Earnings | -$523.5M | -$504.5M | -$468.2M | -$448.5M | -$434.8M | -$404.2M | -$383.4M | -$370.3M |
| Accumulated Other Comp. Income | -$1.51M | -$583K | -$6.0K | $68K | $41K | -$34K | -- | $0 |
| Total Stockholders' Equity | $436.5M | $448.7M | $68.32M | $83.05M | $91.55M | $104.6M | $122.6M | $133.0M |
| Total Equity | $436.5M | $448.7M | $68.32M | $83.05M | $91.55M | $104.6M | $122.6M | $133.0M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$78.26M | -$35.13M | -$31.54M | -$41.66M | -$84.38M | -$63.50M | -$16.07M | -$40.05M | $11.87M | -$16.47M |
| Depreciation & Amortization | $344K | $169K | $158K | $166K | $1.66M | $1.84M | $3.88M | $4.55M | $425K | $27K |
| Stock-Based Compensation | $13.62M | $5.85M | $3.48M | $7.55M | $8.17M | $6.79M | $2.53M | $2.43M | $1.16M | $1.69M |
| Change in Receivables | -- | -- | $0 | $1.06M | $1.12M | -$678K | $1.66M | -$223K | -$247K | -$132K |
| Change in Inventory | -- | $0 | $20K | $18K | -$35K | $18K | $533K | -$311K | -$24K | $0 |
| Change in Payables | -$146K | -$163K | -$2.44M | -$487K | $796K | $99K | $1.02M | $82K | $96K | $332K |
| Operating Cash Flow | -$51.46M | -$49.06M | -$30.68M | -$26.75M | -$70.89M | -$40.54M | -$19.13M | -$3.13M | $12.58M | -$14.57M |
| Capital Expenditure | -- | -- | $0 | -$95K | -$113K | -$63K | -$262K | -$564K | -$23K | -$35K |
| Free Cash Flow | -- | -- | -$30.68M | -$26.85M | -$71.00M | -$40.60M | -$19.40M | -$3.69M | $12.56M | -$14.61M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | $0 | -$1 | -$18.89M | $0 |
| Investing Cash Flow | -$81.72M | $356K | -$133K | -$95K | -$113K | $11.13M | -$443K | $865K | -$18.91M | -$35K |
| Common Stock Issued | $14.76M | $0 | $32.47M | $0 | $29.05M | $35.43M | $8.98M | $0 | $1.69M | $2.00M |
| Financing Cash Flow | $14.59M | $175.8M | $25.04M | -$14.70M | $106.8M | $44.78M | $12.56M | $10.40M | $3.74M | -$1.43M |
| Net Change in Cash | -$118.6M | $127.1M | -$5.77M | -$41.55M | $35.76M | $15.38M | -$7.02M | $8.14M | -$2.60M | -$16.03M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$18.95M | -$36.36M | -$19.63M | -$13.72M | -$30.62M | -$20.77M | -$13.15M | -$35.34M |
| Depreciation & Amortization | $18K | $17K | $17K | $16K | $59K | $134K | $135K | $68K |
| Stock-Based Compensation | $5.22M | $5.30M | $3.58M | $4.51M | $3.15M | $2.72M | $3.24M | $2.90M |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | $0 |
| Change in Payables | -$889K | $2.99M | $219K | -$337K | -$1.89M | $1.69M | $398K | -$1.53M |
| Operating Cash Flow | -$11.54M | -$19.99M | -$17.69M | -$14.25M | -$16.36M | -$11.39M | -$9.46M | -$15.04M |
| Investing Cash Flow | -$11.23M | -$329.9M | $25.50M | $2.40M | -$13.26M | -$70.86M | $0 | $0 |
| Financing Cash Flow | $2.54M | $410.2M | $1.40M | $687K | $14.37M | -$469K | $0 | $67.71M |
| Net Change in Cash | -$20.23M | $60.30M | $9.21M | -$11.16M | -$15.26M | -$82.72M | -$9.46M | $52.66M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | 33.3% | 81.0% | 72.4% | 95.5% | 108.4% | 53.6% | 97.7% | 100.0% |
| Operating Margin | -123601.7% | -15535.6% | -1421.6% | -207.4% | -1521.6% | -1087.4% | -239.1% | -503.4% | 49.9% | -1394.6% |
| Net Profit Margin | -132642.4% | -7965.8% | -1639.5% | -230.8% | -1563.1% | -947.9% | -238.1% | -569.9% | 42.7% | -1428.6% |
| Return on Equity (ROE) | -94.2% | -26.4% | -431.9% | -- | -365.5% | -258.5% | -76.6% | -191.6% | 42.6% | -7957.2% |
| Return on Assets (ROA) | -67.2% | -23.3% | -150.3% | -124.8% | -105.2% | -145.1% | -44.5% | -57.0% | 27.7% | -285.5% |
| Current Ratio | 8.14x | 19.96x | 1.82x | 0.74x | 3.11x | 1.71x | 1.46x | 0.84x | 0.96x | 1.31x |
| Quick Ratio | 7.60x | 19.33x | 1.82x | 0.74x | 3.11x | 1.71x | 1.46x | 0.82x | 0.93x | 1.31x |
| Debt to Equity | 0.01x | 0.01x | 0.26x | -- | 0.11x | 0.06x | 0.06x | 0.74x | 0.00x | 11.37x |
| Revenue Growth (YoY) | -86.6% | -77.1% | -89.3% | +234.4% | -19.4% | -0.8% | -4.0% | -74.7% | +2312.3% | -- |
| Gross Profit Growth (YoY) | -- | -- | -95.6% | +274.1% | -38.9% | -12.5% | +94.2% | -86.1% | +2257.1% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -354.7% | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -437.4% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -385.7% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -124.9% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -129.4% | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -98.8% | -89.3% | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -157.7% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -- | -- | -- | -- | -15536.1% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -- | -7965.8% |
| Return on Equity (ROE) | -20.3% | -22.4% | -124.0% | -94.2% | -109.1% | -44.2% | 59.5% | -26.4% |
| Return on Assets (ROA) | -18.4% | -20.4% | -84.8% | -67.2% | -79.8% | -36.5% | 52.7% | -23.3% |
| Current Ratio | 16.63x | 19.31x | 7.66x | 8.14x | 14.28x | 12.44x | 22.61x | 19.96x |
| Quick Ratio | 19.21x | 22.35x | 7.07x | 7.60x | 14.00x | 12.24x | 22.27x | 19.33x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -100.0% | -- | -- | -66.4% |
| Net Income Growth (YoY) | -- | -- | -- | -- | -232.9% | -121.1% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -323.5% | -145.6% | -- | -- |